Safety and efficacy of cell‐free and concentrated ascites reinfusion therapy against cirrhotic ascites in comparison with malignancy‐related ascites

Background and Aim Cell‐free and concentrated ascites reinfusion therapy (CART) has been performed against cirrhotic ascites, one of the most common complications seen in patients with decompensated cirrhosis. The aim of this study is to investigate its safety and efficacy, and differences in clinical profiles from CART against malignancy‐related ascites with different pathological background. Methods The present investigation involved a...